Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127975751 | 12797575 | 1 | I | 20160420 | 20160928 | 20160930 | 20160930 | EXP | CN-EISAI MEDICAL RESEARCH-EC-2016-020765 | EISAI | 82.00 | YR | M | Y | 80.00000 | KG | 20160930 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127975751 | 12797575 | 1 | PS | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | Oral | Y | 1511010 | 20690 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127975751 | 12797575 | 1 | Dementia Alzheimer's type |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127975751 | 12797575 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127975751 | 12797575 | Asthenia | |
| 127975751 | 12797575 | Blood creatine phosphokinase increased | |
| 127975751 | 12797575 | Cough | |
| 127975751 | 12797575 | Dyspnoea | |
| 127975751 | 12797575 | Incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127975751 | 12797575 | 1 | 20160415 | 20160420 | 0 |